Primary cutaneous adenoid cystic carcinoma of the right forearm: a case report and dermoscopic features - Scorecard - MDSpire

Primary cutaneous adenoid cystic carcinoma of the right forearm: a case report and dermoscopic features

  • By

  • Si Li

  • Xue Cheng

  • Ronggui Xing

  • Zhenyin Peng

  • Tianyou Xiong

  • Yanan Jiang

  • Xianbiao Zou

  • June 16, 2026

  • 0 min

Share

Clinical Scorecard: A Case Study of Primary Cutaneous Adenoid Cystic Carcinoma on the Right Forearm: Dermoscopic and Pathological Insights

At a Glance

CategoryDetail
Condition
Key MechanismsSlow-growing malignant adnexal tumor with neurotropism and high local recurrence rate, necessitating careful management.
Target Population
Care Setting

Key Highlights

  • PCACC presents as a slow-growing, painless, fixed subcutaneous nodule or plaque.
  • Histopathological examination is essential for diagnosis, confirming tumor type and extent.
  • Wide local excision is the standard treatment to minimize local recurrence.
  • Dermoscopy can provide diagnostic clues but is not definitive.
  • Long-term follow-up is necessary due to potential delayed recurrence.

Guideline-Based Recommendations

Diagnosis

  • Histopathological examination is required to confirm diagnosis.
  • Dermoscopy may assist in differential diagnosis.
  • Immunohistochemical markers such as CK, CEA, EMA, and CD117 should be evaluated.

Management

  • Wide local excision is the recommended therapeutic approach.

Monitoring & Follow-up

  • Long-term follow-up is imperative to monitor for recurrence and assess treatment success.

Risks

  • High rate of local recurrence and potential for perineural invasion.

Patient & Prescribing Data

Successful management involves wide local excision with careful monitoring for recurrence.

Clinical Best Practices

  • Consider PCACC in differential diagnosis of slow-growing cutaneous nodules.
  • Perform thorough histopathological evaluation for definitive diagnosis.
  • Ensure negative margins during surgical excision.
  • Utilize imaging to rule out metastatic disease prior to treatment.

Related Resources & Content

Original Source(s)

Related Content